U.S. Household Products Stock News

Booking Holdings (BKNG) is back in focus after first quarter 2026 earnings showed revenue of US$5,532 million and net income of US$1,083 million, alongside a 25-for-1 stock split and refreshed guidance. See our latest analysis for Booking Holdings. Despite the strong first quarter results, the share price has been under pressure, with a 1-day share price return of 0.75% contrasting with a year to date share price return showing a decline of 20.33%. However, the 5 year total shareholder return...

Piper Sandler Companies (PIPR) has entered Q1 2026 with trailing 12 month revenue of about US$1.9b and basic EPS of US$4.22. This is alongside year over year earnings growth of 55.3% and revenue growth of 9.8%. Over the past reported quarters, total revenue has moved from US$484.1 million in Q4 2024 to US$666.1 million in Q4 2025, while quarterly basic EPS has ranged from US$0.55 in Q3 2024 to US$1.69 in Q4 2025. Taken together, these figures present a picture of improving profitability and...

If you are wondering whether Tractor Supply's share price now reflects fair value or an opportunity, starting with a clear look at valuation can help frame your next move. The stock last closed at US$33.83, and recent returns have been weak, with a 7.9% decline over 7 days, 22.8% over 30 days, and 33.4% year to date, along with a 32.3% drop over 1 year. These moves have kept Tractor Supply on many investors' watchlists, as they reassess what the current price says about expectations and...

Zoetis recently expanded the capabilities of its AI-powered Vetscan OptiCell hematology analyzer, while investors and analysts have turned their attention to its upcoming May 7 earnings release and evolving product portfolio. The combination of point-of-care diagnostics innovation and heightened expectations around earnings and companion animal growth is sharpening focus on how Zoetis’ business mix may be evolving. We’ll now examine how the Vetscan OptiCell upgrade could influence Zoetis’...

In late April 2026, Pfizer resolved US patent disputes over its cardiomyopathy drug VYNDAMAX by settling with three generic manufacturers, effectively extending its market exclusivity until June 1, 2031 and consolidating the brand’s position after discontinuing VYNDAQEL in the United States. This legal outcome gives Pfizer clearer medium-term visibility on a key revenue stream in transthyretin-mediated amyloidosis, at the same time as its oncology portfolio advances with positive Phase 3...

In late April 2026, Boeing and several airline customers announced major deals, including Biman Bangladesh Airlines’ largest-ever order for 14 787 Dreamliner and 737 MAX jets, alongside significant new 737 MAX commitments from Copa Airlines and SCAT Airlines, while Boeing also reported first-quarter revenue of US$22,217 million with a net loss of US$4 million. These wins, combined with Boeing’s record-high US$695.00 billion backlog and progress on programs such as the MQ-25A Stingray and...

MSCI Inc. reported first-quarter 2026 results showing sales of US$850.8 million and net income of US$406.0 million, with basic earnings per share from continuing operations of US$5.54, while also completing US$1.35 billion of buybacks under its program announced in October 2025 and affirming a quarterly dividend of US$2.05 per share. These results highlight the earnings impact of higher subscription and asset-based fee revenues, alongside continued capital returns through share repurchases...

O-I Glass, Inc. reported first-quarter 2026 results with sales of US$1,540 million versus US$1,567 million a year earlier, and a net loss of US$73 million, widening from US$16 million, with basic and diluted loss per share from continuing operations at US$0.48 versus US$0.10. Alongside these weaker results, management cut full-year adjusted EPS guidance to US$1.00–US$1.50, citing energy cost inflation and ongoing competitive pressures in Europe despite ongoing Fit to Win cost savings...

Visa (V) just delivered a packed quarterly update, combining higher full-year guidance, a fresh US$20b buyback authorization, and detailed progress in value-added services, stablecoin settlement, and agentic commerce programs. See our latest analysis for Visa. Visa’s packed week of earnings, buybacks, and blockchain and agentic commerce news has come alongside a 9.1% 1 month share price return. Yet year to date the share price return is down 5.3%, while the 3 year total shareholder return is...

In April 2026, Whirlpool’s KitchenAid brand expanded its espresso portfolio with three compact Fully Automatic Espresso Machines with Iced Coffee, priced between US$899.99 and US$1,299.99, featuring quiet grinding, automated milk systems and more than 20 hot and iced drink options. This push into premium, space-saving coffee appliances highlights Whirlpool’s focus on higher-end, feature-rich products that can differentiate its portfolio in a crowded home appliance market. We’ll now examine...

LendingClub recently reported past first-quarter 2026 results showing net income of US$51.6 million, diluted EPS of US$0.44, and a reduction in net charge-offs on loans and leases held for investment to US$42.5 million from US$76.1 million a year earlier. The company also issued second-quarter 2026 EPS guidance of US$0.40–US$0.45, expanded into home improvement lending via a new Wisetack partnership, and completed nearly US$38.0 million of share repurchases under its November 2025 buyback...

In late April 2026, Seagate Technology Holdings reported fiscal third-quarter results showing higher sales, net income, and earnings per share year-on-year, affirmed a US$0.74 quarterly dividend, updated buyback progress, and issued fourth-quarter revenue guidance of about US$3.45 billion, plus or minus US$100 million. Management also highlighted accelerating AI-driven storage demand, nearline capacity being largely allocated through calendar 2027, and continued rollout of advanced...

Devon Energy (NYSE:DVN) has announced plans to acquire Coterra Energy in a move that expands its footprint in the Appalachian Basin. The transaction is positioned as a major step in U.S. shale operations and resource diversification. The deal is expected to reshape how Devon allocates capital across its portfolio of shale assets. For investors watching NYSE:DVN, the planned Coterra acquisition comes after a period of strong share performance, with the stock up 33.5% year to date and 65.0%...

Tyler Technologies (NYSE:TYL) has completed its third largest acquisition, For The Record, adding court recording and transcription technology to its portfolio. The company has updated revenue guidance to reflect FTR and is leaning on the deal to support its shift toward cloud and AI-enabled solutions. Tyler is advancing its cloud migration plan, targeting nearly all new public safety clients and 80% of on premise customers to be in the cloud by 2030. For Tyler Technologies, a long time...

Investors may be wondering whether Arthur J. Gallagher is starting to look interesting at its current price, or if the stock still has room to fall before it feels like good value. The shares closed at US$208.11 recently, with returns of a 3.4% decline over 7 days, a 4.4% decline over 30 days, an 18.7% decline year to date and a 36.5% decline over the past year. This compares with a more muted 0.1% return over 3 years and a 45.1% gain over 5 years. These moves have arrived alongside ongoing...

Lease event sets the stage for Terreno Realty Terreno Realty (TRNO) recently executed a lease for a 10.2 acre transshipment facility in Hayward, California with a fully autonomous all electric ride hailing provider, running from March 2026 through March 2031. See our latest analysis for Terreno Realty. This lease comes as Terreno Realty’s share price has climbed 10.6% year to date and 6.0% over the past 90 days, while its 1 year total shareholder return sits at 17.3%, which some investors may...

Vertex Pharmaceuticals (VRTX) is back in focus after the US Food and Drug Administration approved expanded use of ALYFTREK for cystic fibrosis patients aged 6 and older, alongside supportive commentary from Bank of America on its core franchises. See our latest analysis for Vertex Pharmaceuticals. Despite the positive ALYFTREK decision and supportive commentary from Bank of America, the share price has seen a 10.19% decline over 90 days and a 6.24% year to date share price return. The 5 year...

Wondering if Fluor at around US$53 a share still offers value, or if the easy gains are behind it? This breakdown is designed to help you frame that question clearly. The stock has posted returns of 9.9% over 7 days, 12.4% over 30 days, 27.1% year to date, 48.2% over 1 year, 94.8% over 3 years, and 114.7% over 5 years. That puts recent valuation questions front and center for many investors. These moves sit against a backdrop of ongoing interest in large engineering and construction...

Nabors Industries (NBR) has been in focus after reporting higher Q1 2026 operating revenues, a net loss tied to the absence of a prior one time gain, and meaningful debt reduction through senior note redemptions. See our latest analysis for Nabors Industries. After a strong run that includes an 82.26% year to date share price return and a very large 1 year total shareholder return of 251.32%, Nabors Industries is consolidating near US$100.97 as investors weigh recent revenue growth, debt...

Why Riot Platforms is on investors’ radar today Riot Platforms (RIOT) has been drawing attention after recent trading, with the share price last closing at US$18.50 and returns over the past month and past 3 months standing out against its longer track record. See our latest analysis for Riot Platforms. Recent trading has been volatile, with a 1 day share price return of 7.31% set against a 30 day share price return of 43.86% and a 1 year total shareholder return of 120.50%. This suggests...

If you are wondering whether Dorman Products is attractively priced or looking stretched at around US$112.88, this article walks through the numbers that matter for valuation. The stock price sits at US$112.88, with returns of 1.5% over the last week, 11.9% over the last month, a 9.0% decline year to date, and a 2.1% decline over the last year. These returns are set against 27.7% and 8.1% over the past 3 and 5 years. Recent news coverage has focused on Dorman Products in the context of...

What Recent Performance Says About American International Group (AIG) With no single headline event driving attention to American International Group (AIG), recent price performance and fundamentals are doing most of the talking for investors watching this large global insurer. See our latest analysis for American International Group. Recent trading has swung positive, with a 1-day share price return of 5.31% lifting AIG to US$78.77 and adding to a 6.56% 90-day share price return. This comes...

Wondering if Lumentum Holdings at around US$949.93 is priced for perfection or still leaves room on the table? This article walks through what that share price might really be implying. The stock has shown sharp moves recently, with returns of 7.7% over 7 days, 14.9% over 30 days, 146.0% year to date, a very large 1 year return, an 18.9x 3 year gain and more than 10x over 5 years. These sharp moves have drawn fresh attention to Lumentum as investors reassess what they are willing to pay for...

Investors may be considering whether AGNC Investment is still sensibly priced after a strong run, or whether recent returns have already incorporated most of the potential upside. The stock recently closed at US$10.94, with a 7.8% move over 30 days, a small 0.1% gain year to date, and a 43.5% return over the last year that may have shifted how the market views its risk and reward profile. Recent coverage has focused on AGNC Investment's role as a mortgage REIT and how changing expectations...